Bitter-sweet symphony: glycan–lectin interactions in virus biology
暂无分享,去创建一个
H. Favoreel | H. Nauwynck | R. D. de Groot | S. Pöhlmann | W. Van Breedam | Wander Van Breedam | Stefan Pöhlmann | Herman W Favoreel | Raoul J de Groot | Hans J Nauwynck
[1] W. Zimmermann,et al. The Core 2 β-1,6-N-Acetylglucosaminyltransferase-Mucin Encoded by Bovine Herpesvirus 4 Was Acquired from an Ancestor of the African Buffalo , 2003, Journal of Virology.
[2] E. Freed,et al. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures , 1996, Journal of virology.
[3] S. Pöhlmann,et al. The multiple facets of HIV attachment to dendritic cell lectins , 2010, Cellular microbiology.
[4] H. Klenk,et al. Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. , 1986, The Journal of biological chemistry.
[5] S. Hawgood,et al. Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. , 2002, American journal of respiratory cell and molecular biology.
[6] R. Compans,et al. Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. , 2005, Virology.
[7] L. Enjuanes,et al. Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity , 1996, Journal of virology.
[8] Robert B Sim,et al. Lung surfactant protein A provides a route of entry for respiratory syncytial virus into host cells. , 2000, Viral immunology.
[9] E. De Clercq,et al. Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins , 2004, Journal of Virology.
[10] M. Malim,et al. cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor , 2001, Journal of Virology.
[11] S. Gringhuis,et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. , 2007, Immunity.
[12] Li Wu,et al. Functionally Distinct Transmission of Human Immunodeficiency Virus Type 1 Mediated by Immature and Mature Dendritic Cells , 2007, Journal of Virology.
[13] M. Harmsen,et al. Interactions of surfactant protein A with influenza A viruses: binding and neutralization. , 1995, The Journal of infectious diseases.
[14] K. Van Laethem,et al. Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use , 2010, Antimicrobial Agents and Chemotherapy.
[15] M. Ouellet,et al. Glycans, galectins, and HIV‐1 infection , 2012, Annals of the New York Academy of Sciences.
[16] O. Spiller,et al. The relevance of complement to virus biology , 2004, Virology.
[17] Xi Jiang,et al. Norovirus and Histo-Blood Group Antigens: Demonstration of a Wide Spectrum of Strain Specificities and Classification of Two Major Binding Groups among Multiple Binding Patterns , 2005, Journal of Virology.
[18] K. Hartshorn,et al. Porcine surfactant protein D is N-glycosylated in its carbohydrate recognition domain and is assembled into differently charged oligomers. , 2002, American journal of respiratory cell and molecular biology.
[19] B. Benaissa-Trouw,et al. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages , 1997, European journal of immunology.
[20] K. Zaner,et al. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. , 2000, The Biochemical journal.
[21] J. Whitsett,et al. Correction of Pulmonary Abnormalities in Sftpd-/- Mice Requires the Collagenous Domain of Surfactant Protein D* , 2006, Journal of Biological Chemistry.
[22] M. Jiang,et al. Glycosphingolipids as Receptors for Non-Enveloped Viruses , 2010, Viruses.
[23] J. Garcia-Vallejo,et al. Endogenous ligands for C‐type lectin receptors: the true regulators of immune homeostasis , 2009, Immunological reviews.
[24] R. Doms,et al. Diversity of receptors binding HIV on dendritic cell subsets , 2002, Nature Immunology.
[25] J. Jensenius,et al. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. , 1996, Blood.
[26] S. Mummidi,et al. Extensive Repertoire of Membrane-bound and Soluble Dendritic Cell-specific ICAM-3-grabbing Nonintegrin 1 (DC-SIGN1) and DC-SIGN2 Isoforms , 2001, The Journal of Biological Chemistry.
[27] Andrew Rambaut,et al. Pacing a small cage: mutation and RNA viruses , 2008, Trends in Ecology & Evolution.
[28] R. Kannagi,et al. Transactivation of the fucosyltransferase VII gene by human T-cell leukemia virus type 1 Tax through a variant cAMP-responsive element. , 2003, Blood.
[29] J. Le Pendu,et al. Binding of Rabbit Hemorrhagic Disease Virus to Antigens of the ABH Histo-Blood Group Family , 2000, Journal of Virology.
[30] Jianpeng Ma,et al. Structural basis for receptor specificity of influenza B virus hemagglutinin , 2007, Proceedings of the National Academy of Sciences.
[31] Barbara Imperiali,et al. The expanding horizons of asparagine-linked glycosylation. , 2011, Biochemistry.
[32] M. Tate,et al. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice , 2009, Respiratory research.
[33] J. Goedert,et al. Association of DC-SIGN Promoter Polymorphism with Increased Risk for Parenteral, but Not Mucosal, Acquisition of Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.
[34] R. Dwek,et al. Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections , 2002, Journal of Virology.
[35] K. Tomer,et al. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. , 2000, Biochemistry.
[36] W. Greene,et al. In Vitro Derived Dendritic Cells trans-Infect CD4 T Cells Primarily with Surface-Bound HIV-1 Virions , 2007, PLoS pathogens.
[37] Raul Andino,et al. Quasispecies Theory and the Behavior of RNA Viruses , 2010, PLoS pathogens.
[38] S. Subramaniam,et al. HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. , 2011, Blood.
[39] D. McDonald,et al. Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.
[40] P. Lozach,et al. Infection of Dendritic Cells (DCs), Not DC-SIGN-Mediated Internalization of Human Immunodeficiency Virus, Is Required for Long-Term Transfer of Virus to T Cells , 2006, Journal of Virology.
[41] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[42] S. Maurer-Stroh,et al. Addition of Glycosylation to Influenza A Virus Hemagglutinin Modulates Antibody-Mediated Recognition of H1N1 2009 Pandemic Viruses , 2013, The Journal of Immunology.
[43] T. Tumpey,et al. N-Linked Glycosylation of the Hemagglutinin Protein Influences Virulence and Antigenicity of the 1918 Pandemic and Seasonal H1N1 Influenza A Viruses , 2013, Journal of Virology.
[44] K. Prydz,et al. Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.
[45] R. Hegde,et al. Structural Basis for the Receptor Binding Specificity of Norwalk Virus , 2008, Journal of Virology.
[46] J. Abastado,et al. Covert Human Immunodeficiency Virus Replication in Dendritic Cells and in DC-SIGN-Expressing Cells Promotes Long-Term Transmission to Lymphocytes , 2005, Journal of Virology.
[47] E. Soilleux,et al. Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN+ Cells in Human Rectal Mucosa , 2005, Journal of Virology.
[48] Fang Fang,et al. Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein , 2009, PloS one.
[49] J. Balzarini,et al. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions. , 2007, Virology.
[50] G. Rabinovich,et al. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms. , 2011, International immunopharmacology.
[51] D. Knight,et al. Cytomegalovirus induces sialyl Lewis(x) and Lewis(x) on human endothelial cells. , 2000, Transplantation.
[52] J. V. Van Etten,et al. Glycosyltransferases encoded by viruses. , 2004, The Journal of general virology.
[53] J. Balzarini,et al. Potential of carbohydrate‐binding agents as therapeutics against enveloped viruses , 2010, Medicinal research reviews.
[54] G. Screaton,et al. Lectin Switching During Dengue Virus Infection , 2011, The Journal of infectious diseases.
[55] Y. Kooyk,et al. Protein-glycan interactions in the control of innate and adaptive immune responses , 2008, Nature Immunology.
[56] R. Means,et al. A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.
[57] Steven J. Gamblin,et al. Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins , 2010, The Journal of Biological Chemistry.
[58] R. Dwek,et al. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. , 2007, Antiviral research.
[59] Yoshiyuki Suzuki,et al. Evidence for N-Glycan Shielding of Antigenic Sites during Evolution of Human Influenza A Virus Hemagglutinin , 2012, Journal of Virology.
[60] Yufei Wang,et al. DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4 , 2011, PloS one.
[61] J. Roth,et al. Protein glycosylation in the endoplasmic reticulum and the Golgi apparatus and cell type-specificity of cell surface glycoconjugate expression: analysis by the protein A-gold and lectin-gold techniques , 1996, Histochemistry and Cell Biology.
[62] S. Thiel,et al. Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection , 2010, BMC Immunology.
[63] W. Hendrickson,et al. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. , 2002, Immunity.
[64] A. Tamanini,et al. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.
[65] A. Simmons,et al. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication , 2007, Nature Immunology.
[66] G. Gaiha,et al. Surfactant Protein D Modulates HIV Infection of Both T-Cells and Dendritic Cells , 2013, PloS one.
[67] M. Aebi,et al. Mechanisms and principles of N-linked protein glycosylation. , 2011, Current opinion in structural biology.
[68] K. Ogino,et al. RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. , 2007, AIDS research and human retroviruses.
[69] Á. Corbí,et al. Structural Requirements for Multimerization of the Pathogen Receptor Dendritic Cell-specific ICAM3-grabbing Non-integrin (CD209) on the Cell Surface* , 2008, Journal of Biological Chemistry.
[70] E. Garman,et al. Controlling influenza by inhibiting the virus's neuraminidase. , 2004, Current drug targets.
[71] M. Wiznerowicz,et al. Lentivirus-mediated Rna Interference of Dc-sign Expression Inhibits Human Immunodeficiency Virus Transmission from Dendritic Cells to T Cells in the Early Events of Human Immunodeficiency Virus Type 1 (hiv-1) Infection, Immature Dendritic Cells (dcs) Expressing the Dc-specific Intercellular Adhesion , 2022 .
[72] Mark von Itzstein,et al. Anti-influenza drugs: the development of sialidase inhibitors. , 2009, Handbook of experimental pharmacology.
[73] E. Dittmann,et al. Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile* , 2010, The Journal of Biological Chemistry.
[74] Yanjun Liu,et al. Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus , 2007, Journal of Virology.
[75] A. Gottschalk. Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. , 1957, Biochimica et biophysica acta.
[76] Julie Nieminen,et al. Galectins in innate immunity: dual functions of host soluble β‐galactoside‐binding lectins as damage‐associated molecular patterns (DAMPs) and as receptors for pathogen‐associated molecular patterns (PAMPs) , 2009, Immunological reviews.
[77] DavidE . Goldberg,et al. Activation of Murine CD4+ and CD8+ T Lymphocytes Leads to Dramatic Remodeling of N-Linked Glycans1 , 2006, The Journal of Immunology.
[78] J. Whitsett,et al. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. , 2004, American journal of respiratory cell and molecular biology.
[79] N. Krishna,et al. NMR experiments reveal the molecular basis of receptor recognition by a calicivirus. , 2008, Journal of the American Chemical Society.
[80] Kai Ludwig,et al. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. , 2010, Small.
[81] R. Haag,et al. Inhibition of Influenza Virus Activity by Multivalent Glycoarchitectures with Matched Sizes , 2011, Chembiochem : a European journal of chemical biology.
[82] O. Larm,et al. Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. , 2002, Virology.
[83] D. Littman,et al. Dendritic Cell-Mediated trans-Enhancement of Human Immunodeficiency Virus Type 1 Infectivity Is Independent of DC-SIGN , 2006, Journal of Virology.
[84] Benhur Lee,et al. Identification of the Optimal DC-SIGN Binding Site on Human Immunodeficiency Virus Type 1 gp120 , 2007, Journal of Virology.
[85] J. Lifson,et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. , 2004, Blood.
[86] Remy Loris,et al. Principles of structures of animal and plant lectins. , 2002, Biochimica et biophysica acta.
[87] M. Fukuda,et al. The core 2 beta-1,6-N-acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to post-translational modifications of structural proteins. , 2004, The Journal of general virology.
[88] S. Thiel,et al. Binding of human collectins (SP-A and MBP) to influenza virus. , 1994, The Biochemical journal.
[89] Masatoshi Nei,et al. Origin and evolution of influenza virus hemagglutinin genes. , 2002, Molecular biology and evolution.
[90] H. Nauwynck,et al. The M/GP5 Glycoprotein Complex of Porcine Reproductive and Respiratory Syndrome Virus Binds the Sialoadhesin Receptor in a Sialic Acid-Dependent Manner , 2010, PLoS pathogens.
[91] T. Takeshita,et al. Inhibition of DC‐SIGN‐mediated transmission of human immunodeficiency virus type 1 by Toll‐like receptor 3 signalling in breast milk macrophages , 2010, Immunology.
[92] John P. Moore,et al. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. , 2010, Virology.
[93] Siamon Gordon,et al. Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.
[94] Ajit Varki,et al. Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.
[95] L. Aschenbrenner,et al. Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181. , 2011, The Journal of antimicrobial chemotherapy.
[96] M. Clerici,et al. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models , 2012, AIDS.
[97] J. Goerke,et al. Pulmonary Collectins Modulate Strain-Specific Influenza A Virus Infection and Host Responses , 2004, Journal of Virology.
[98] J. Rodríguez-Fernández,et al. DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-β, and Anti-Inflammatory Agents1 , 2002, The Journal of Immunology.
[99] R. Compans,et al. Posttranslational modification and intracellular transport of mumps virus glycoproteins , 1983, Journal of virology.
[100] S. Swaminathan,et al. CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[101] S. Gordon,et al. Ligand recognition by antigen-presenting cell C-type lectin receptors , 2004, Current Opinion in Immunology.
[102] G. Herrler,et al. The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant , 1991, Journal of virology.
[103] G. Herrler,et al. Structural and Functional Analysis of the Surface Protein of Human Coronavirus OC43 , 1993, Virology.
[104] R. Geyer,et al. Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates. , 1994, Glycobiology.
[105] Simon C Watkins,et al. DC-SIGN on B Lymphocytes Is Required For Transmission of HIV-1 to T Lymphocytes , 2006, PLoS pathogens.
[106] H. Nauwynck,et al. Involvement of the Matrix Protein in Attachment of Porcine Reproductive and Respiratory Syndrome Virus to a Heparinlike Receptor on Porcine Alveolar Macrophages , 2002, Journal of Virology.
[107] Jianpeng Ma,et al. Crystal Structure of Unliganded Influenza B Virus Hemagglutinin , 2008, Journal of Virology.
[108] C. Reis e Sousa,et al. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. , 2012, Annual review of immunology.
[109] A. Dell,et al. Endothelial Galectin-1 Binds to Specific Glycans on Nipah Virus Fusion Protein and Inhibits Maturation, Mobility, and Function to Block Syncytia Formation , 2010, PLoS pathogens.
[110] T. Merry,et al. Alternative approaches to antiviral treatments: focusing on glycosylation as a target for antiviral therapy , 2010, Biotechnology and applied biochemistry.
[111] R. Lamb,et al. Orthomyxoviridae: The Viruses and Their Replication. , 1996 .
[112] J. Jensenius,et al. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[113] A. Schmitt,et al. Paramyxovirus assembly and budding: building particles that transmit infections. , 2010, The international journal of biochemistry & cell biology.
[114] Dennis R Burton,et al. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens , 2010, Proceedings of the National Academy of Sciences.
[115] S. Gringhuis,et al. Signalling through C-type lectin receptors: shaping immune responses , 2009, Nature Reviews Immunology.
[116] R. Cummings,et al. Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans , 2006, FEBS letters.
[117] J. Le Pendu,et al. Mendelian resistance to human norovirus infections , 2006, Seminars in Immunology.
[118] S. Gringhuis,et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells , 2010, Nature Immunology.
[119] R. Yu,et al. Structures, biosynthesis, and functions of gangliosides--an overview. , 2011, Journal of oleo science.
[120] T. Kuiken,et al. Assessment of the Antiviral Properties of Recombinant Porcine SP-D against Various Influenza A Viruses In Vitro , 2011, PloS one.
[121] H. Klenk,et al. Natural and synthetic sialic acid‐containing inhibitors of influenza virus receptor binding , 2003, Reviews in medical virology.
[122] J. Skehel,et al. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.
[123] Nicole Zitzmann,et al. α‐Glucosidase inhibitors as potential broad based anti‐viral agents , 1998, FEBS letters.
[124] Kristen D Yetming,et al. Murine Noroviruses Bind Glycolipid and Glycoprotein Attachment Receptors in a Strain-Dependent Manner , 2012, Journal of Virology.
[125] S. Mercier,et al. Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. , 2008, Virology.
[126] D. Montefiori,et al. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[127] J. Balzarini. The α(1,2)‐mannosidase I inhibitor 1‐deoxymannojirimycin potentiates the antiviral activity of carbohydrate‐binding agents against wild‐type and mutant HIV‐1 strains containing glycan deletions in gp120 , 2007, FEBS Letters.
[128] R. Johnston,et al. Adaptation of Sindbis Virus to BHK Cells Selects for Use of Heparan Sulfate as an Attachment Receptor , 1998, Journal of Virology.
[129] K. Hartshorn,et al. Porcine Pulmonary Collectins Show Distinct Interactions with Influenza A Viruses: Role of the N-Linked Oligosaccharides in the Carbohydrate Recognition Domain1 , 2003, The Journal of Immunology.
[130] R. Doms,et al. Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived Dendritic Cells , 2002, Journal of Virology.
[131] L. Enjuanes,et al. The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus , 2011, Virology Journal.
[132] R. P. Aaronson,et al. Influenza C virus hemagglutinin: comparison with influenza A and B virus hemagglutinins , 1984, Journal of virology.
[133] Sera,et al. Distinct glycoprotein inhibitors of influenza A virus in different animal sera , 1991, Journal of virology.
[134] H. Klenk,et al. Isolation and characterization of sialate 9(4)-O-acetylesterase from influenza C virus. , 1988, Biological chemistry Hoppe-Seyler.
[135] R. Dwek,et al. Exploiting the defensive sugars of HIV-1 for drug and vaccine design , 2007, Nature.
[136] S. Gringhuis,et al. Innate signaling in HIV-1 infection of dendritic cells. , 2011, Current opinion in HIV and AIDS.
[137] A. Pajot,et al. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. , 2006, Blood.
[138] H. Ikematsu,et al. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza , 2011, Expert review of anti-infective therapy.
[139] H. Klenk,et al. The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor. , 1988, The Journal of general virology.
[140] R. Steinman,et al. Dendritic Cell-Specific Intercellular Adhesion Molecule 3-Grabbing Nonintegrin/CD209 Is Abundant on Macrophages in the Normal Human Lymph Node and Is Not Required for Dendritic Cell Stimulation of the Mixed Leukocyte Reaction1 , 2005, The Journal of Immunology.
[141] Chih-Jen Wei,et al. Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design , 2010, Science Translational Medicine.
[142] G. Gaiha,et al. Surfactant Protein A Binds to HIV and Inhibits Direct Infection of CD4+ Cells, but Enhances Dendritic Cell-Mediated Viral Transfer1 , 2008, The Journal of Immunology.
[143] P. Colman. Influenza virus neuraminidase: Structure, antibodies, and inhibitors , 1994, Protein science : a publication of the Protein Society.
[144] Andrew G. Brooks,et al. Specific Sites of N-Linked Glycosylation on the Hemagglutinin of H1N1 Subtype Influenza A Virus Determine Sensitivity to Inhibitors of the Innate Immune System and Virulence in Mice , 2011, The Journal of Immunology.
[145] Xiaowu Chen,et al. Neuraminidase Inhibitors as Anti-Influenza Virus Agents , 1999, Antiviral chemistry & chemotherapy.
[146] H. Klenk,et al. Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. , 2000, The Journal of general virology.
[147] H. Tsutsumi,et al. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection , 2003, European journal of immunology.
[148] S. Penadés,et al. Multivalent Manno‐Glyconanoparticles Inhibit DC‐SIGN‐Mediated HIV‐1 Trans‐Infection of Human T Cells , 2009, Chembiochem : a European journal of chemical biology.
[149] T. Krusat,et al. Heparin-dependent attachment ofrespiratory syncytial virus (RSV) to host cells , 1997, Archives of Virology.
[150] D. Eisen,et al. Impact of mannose-binding lectin on susceptibility to infectious diseases. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[151] A. Fauci,et al. Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor , 2012, Proceedings of the National Academy of Sciences.
[152] Alessio Ceroni,et al. Characterizing the glycome of the mammalian immune system , 2008, Immunology and cell biology.
[153] Gemma L. J. Fuller,et al. DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets , 2006, Journal of Virology.
[154] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[155] Marion C Lanteri,et al. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. , 2003, Glycobiology.
[156] V. KewalRamani,et al. Dendritic-cell interactions with HIV: infection and viral dissemination , 2006, Nature Reviews Immunology.
[157] G. Herrler,et al. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus , 1997, Journal of virology.
[158] K. Hartshorn,et al. Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. , 2004, American journal of respiratory cell and molecular biology.
[159] Sachiko Sato,et al. Galectin-1 Acts as a Soluble Host Factor That Promotes HIV-1 Infectivity through Stabilization of Virus Attachment to Host Cells1 , 2005, The Journal of Immunology.
[160] C. Mandl,et al. Adaptation of Tick-Borne Encephalitis Virus to BHK-21 Cells Results in the Formation of Multiple Heparan Sulfate Binding Sites in the Envelope Protein and Attenuation In Vivo , 2001, Journal of Virology.
[161] F. Gago,et al. Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes , 2006, Journal of Virology.
[162] D. Durantel. Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. , 2009, Current opinion in investigational drugs.
[163] C. Kelly,et al. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. , 2009, Chemistry.
[164] R. Webster,et al. Sialoglycoproteins that bind influenza A virus and resist viral neuraminidase in different animal sera. , 1994, The Journal of general virology.
[165] R. Kannagi,et al. Human T-cell leukemia virus-1 encoded Tax protein transactivates alpha 1-->3 fucosyltransferase Fuc-T VII, which synthesizes sialyl Lewis X, a selectin ligand expressed on adult T-cell leukemia cells. , 1997, Biochemical and biophysical research communications.
[166] J. Paulson,et al. Basis for the potent inhibition of influenza virus infection by equine and guinea pig alpha 2-macroglobulin. , 1989, The Journal of biological chemistry.
[167] Carolyn R. Bertozzi,et al. The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins† , 2008, Biochemistry.
[168] Maureen E. Taylor,et al. Introduction to glycobiology , 2003 .
[169] R. Baric,et al. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations , 2008, Immunological reviews.
[170] Oscar A. Negrete,et al. N-Glycans on Nipah Virus Fusion Protein Protect against Neutralization but Reduce Membrane Fusion and Viral Entry , 2006, Journal of Virology.
[171] C. Mervis,et al. Rearrangements of the Williams–Beuren syndrome locus: molecular basis and implications for speech and language development , 2007, Expert Reviews in Molecular Medicine.
[172] R. Doms,et al. DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus , 2001, Journal of Virology.
[173] F. Hayden,et al. Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection , 2006, Antimicrobial Agents and Chemotherapy.
[174] K. Van Laethem,et al. Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity , 2011, Retrovirology.
[175] H. Nauwynck,et al. Effects of heparin on the entry of porcine reproductive and respiratory syndrome virus into alveolar macrophages. , 2001, Advances in experimental medicine and biology.
[176] J. Reynolds,et al. RNAi-directed inhibition of DC-SIGN by dendritic cells: Prospects for HIV-1 therapy , 2005, The AAPS Journal.
[177] Y. Kawaoka,et al. Alpha 2-macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum. , 1993, Virology.
[178] N. Klein,et al. Mannose‐binding lectin in innate immunity: past, present and future , 2006, Tissue antigens.
[179] Andrzej T Galecki,et al. Prevention of influenza pneumonitis by sialic Acid-conjugated dendritic polymers. , 2002, The Journal of infectious diseases.
[180] Raymond A. Dwek,et al. Targeting glycosylation as a therapeutic approach , 2002, Nature Reviews Drug Discovery.
[181] M. Hart,et al. Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin. , 2003, The Journal of general virology.
[182] Benhur Lee,et al. Modes of paramyxovirus fusion: a Henipavirus perspective. , 2011, Trends in microbiology.
[183] M. Tate,et al. Glycosylation as a target for recognition of influenza viruses by the innate immune system. , 2007, Advances in experimental medicine and biology.
[184] Mark von Itzstein,et al. The war against influenza: discovery and development of sialidase inhibitors. , 2007, Nature reviews. Drug discovery.
[185] J. McCullers,et al. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. , 2011, American journal of respiratory and critical care medicine.
[186] P. Reading,et al. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. , 1995, Biochemical and biophysical research communications.
[187] Anavaj Sakuntabhai,et al. A variant in the CD209 promoter is associated with severity of dengue disease , 2005, Nature Genetics.
[188] T. Fujita. Evolution of the lectin–complement pathway and its role in innate immunity , 2002, Nature Reviews Immunology.
[189] J. Skehel,et al. Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus , 1998, Nature.
[190] H. Bokhari,et al. Selection of predicted siRNA as potential antiviral therapeutic agent against influenza virus , 2011, Bioinformation.
[191] V. Huber,et al. Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays , 2011, Influenza and other respiratory viruses.
[192] L. Stamatatos,et al. Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A , 2005, Journal of Virology.
[193] V. Hascall,et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. , 1993, AIDS research and human retroviruses.
[194] M. Hulst,et al. Passage of Classical Swine Fever Virus in Cultured Swine Kidney Cells Selects Virus Variants That Bind to Heparan Sulfate due to a Single Amino Acid Change in Envelope Protein Erns , 2000, Journal of Virology.
[195] B. Shaanan,et al. Lectin-carbohydrate interactions: different folds, common recognition principles. , 1997, Trends in biochemical sciences.
[196] Alessandra Cambi,et al. Dual function of C-type lectin-like receptors in the immune system. , 2003, Current opinion in cell biology.
[197] K. Hartshorn,et al. Human mannose-binding protein functions as an opsonin for influenza A viruses. , 1993, The Journal of clinical investigation.
[198] R. Geyer,et al. Host-cell-specific glycosylation of HIV-2 envelope glycoprotein , 1997, Glycoconjugate Journal.
[199] Chi-Huey Wong,et al. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN , 2008, Proceedings of the National Academy of Sciences.
[200] Hiroki Inoue,et al. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. , 2010, Journal of medicinal chemistry.
[201] H. Klenk,et al. Structure and Function of the Hef Glycoprotein of Influenza C Virus , 1991, Advances in Virus Research.
[202] D. Burton,et al. The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade , 2011, PloS one.
[203] H. Klenk,et al. Neuraminic acid is involved in the binding of influenza C virus to erythrocytes. , 1985, Virology.
[204] T. Geijtenbeek,et al. Viral piracy: HIV-1 targets dendritic cells for transmission. , 2006, Current HIV research.
[205] G. McFadden,et al. The complete genome sequence of shope (rabbit) fibroma virus. , 1999, Virology.
[206] Jianzhu Chen,et al. Use of siRNAs to prevent and treat influenza virus infection. , 2004, Virus research.
[207] Morgan A Reuter,et al. HIV Traffics through a Specialized, Surface-Accessible Intracellular Compartment during trans-Infection of T Cells by Mature Dendritic Cells , 2008, PLoS pathogens.
[208] M. Tremblay,et al. Host-Soluble Galectin-1 Promotes HIV-1 Replication through a Direct Interaction with Glycans of Viral gp120 and Host CD4 , 2011, Journal of Virology.
[209] Fang Fang,et al. Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein , 2009, PloS one.
[210] A. Sewell,et al. Dendritic cells and transmission of HIV-1. , 2001, Trends in immunology.
[211] B M Curtis,et al. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[212] G. Vanham,et al. Carbohydrate-Binding Agents Efficiently Prevent Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Nonintegrin (DC-SIGN)-Directed HIV-1 Transmission to T Lymphocytes , 2007, Molecular Pharmacology.
[213] H. Nauwynck,et al. Porcine Arterivirus Infection of Alveolar Macrophages Is Mediated by Sialic Acid on the Virus , 2004, Journal of Virology.
[214] R. Steinman,et al. The interaction of HIV with dendritic cells: outcomes and pathways , 2007, Trends in Immunology.
[215] J. Le Pendu,et al. Association between expression of the H histo-blood group antigen, alpha1,2fucosyltransferases polymorphism of wild rabbits, and sensitivity to rabbit hemorrhagic disease virus. , 2008, Glycobiology.
[216] R. Doms,et al. The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. , 2001, Virology.
[217] G. Taylor,et al. Neuraminidase inhibitors as antiviral agents. , 2005, Current drug targets. Infectious disorders.
[218] K. Van Laethem,et al. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. , 2007, Virology.
[219] Haruko Shirato. Norovirus and histo-blood group antigens. , 2011, Japanese journal of infectious diseases.
[220] R. Cross,et al. Genetic Diversity and Histo-Blood Group Antigen Interactions of Rhesus Enteric Caliciviruses , 2010, Journal of Virology.
[221] A. Dell,et al. Dendritic Cell Maturation Results in Pronounced Changes in Glycan Expression Affecting Recognition by Siglecs and Galectins1 , 2007, The Journal of Immunology.
[222] J. Münch,et al. Platelet activation suppresses HIV-1 infection of T cells , 2013, Retrovirology.
[223] Zhu-Nan Li,et al. Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. , 2002, The Journal of general virology.
[224] U. Gimsa,et al. Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity. , 1996, Virus research.
[225] H. Nauwynck,et al. Porcine Arterivirus Attachment to the Macrophage-Specific Receptor Sialoadhesin Is Dependent on the Sialic Acid-Binding Activity of the N-Terminal Immunoglobulin Domain of Sialoadhesin , 2007, Journal of Virology.
[226] A. Stuart,et al. Alpha2,6-linked sialic acid acts as a receptor for Feline calicivirus. , 2007, The Journal of general virology.
[227] H. Klenk,et al. Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics , 2000, Journal of Virology.
[228] A. M. Hutson,et al. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus , 2008, Proceedings of the National Academy of Sciences.
[229] S. Kornfeld,et al. Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses , 1977, Journal of virology.
[230] R. Jackson,et al. Myxoma Virus Encodes an α2,3-Sialyltransferase That Enhances Virulence , 1999, Journal of Virology.
[231] M. Matrosovich,et al. Influenza viruses differ in recognition of 4-O-acetyl substitution of sialic acid receptor determinant. , 1992, Virology.
[232] E. De Clercq,et al. Marked Depletion of Glycosylation Sites in HIV-1 gp120 under Selection Pressure by the Mannose-Specific Plant Lectins of Hippeastrum Hybrid and Galanthus nivalis , 2005, Molecular Pharmacology.
[233] C. Figdor,et al. How C‐type lectins detect pathogens , 2005, Cellular microbiology.
[234] Xi Jiang,et al. Norovirus–host interaction: implications for disease control and prevention , 2007, Expert Reviews in Molecular Medicine.
[235] J. Balzarini. Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? , 2007, Antiviral chemistry & chemotherapy.
[236] M. Seidel,et al. Mannan-binding lectin deficiency - Good news, bad news, doesn't matter? , 2012, Clinical immunology.
[237] Jan Balzarini,et al. Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus , 2006, Journal of Virology.
[238] Benhur Lee,et al. Novel Innate Immune Functions for Galectin-1: Galectin-1 Inhibits Cell Fusion by Nipah Virus Envelope Glycoproteins and Augments Dendritic Cell Secretion of Proinflammatory Cytokines1 , 2005, The Journal of Immunology.
[239] J. Abastado,et al. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. , 2004, Blood.
[240] R. Samulski,et al. Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.
[241] J. Balzarini. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy , 2007, Nature Reviews Microbiology.
[242] B. Barrère,et al. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture , 1997, Archives of Virology.
[243] S. Gordon,et al. Divergent roles for C-type lectins expressed by cells of the innate immune system. , 2004, Molecular immunology.
[244] E. Veldhuizen,et al. The carbohydrate recognition domain of collectins , 2011, The FEBS journal.
[245] Jesús Jiménez-Barbero,et al. From lectin structure to functional glycomics: principles of the sugar code. , 2011, Trends in biochemical sciences.
[246] W. Weis,et al. Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR , 2001, Science.
[247] D. Stuart,et al. Shared paramyxoviral glycoprotein architecture is adapted for diverse attachment strategies , 2010, Biochemical Society transactions.
[248] Emilio J. Gualda,et al. The Neck Region of the C-type Lectin DC-SIGN Regulates Its Surface Spatiotemporal Organization and Virus-binding Capacity on Antigen-presenting Cells* , 2012, The Journal of Biological Chemistry.
[249] Y. Kawaoka,et al. Molecular Mechanisms of Serum Resistance of Human Influenza H3N2 Virus and Their Involvement in Virus Adaptation in a New Host , 1998, Journal of Virology.
[250] Y. Kooyk,et al. C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB , 2007 .
[251] L. Morey,et al. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice , 1997, Journal of virology.
[252] K. Hartshorn,et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. , 1994, The Journal of clinical investigation.
[253] G. McFadden,et al. Post-translational modification of the myxoma-virus anti-inflammatory serpin SERP-1 by a virally encoded sialyltransferase. , 2000, The Biochemical journal.
[254] R. Doms,et al. A Yeast Glycoprotein Shows High-Affinity Binding to the Broadly Neutralizing Human Immunodeficiency Virus Antibody 2G12 and Inhibits gp120 Interactions with 2G12 and DC-SIGN , 2009, Journal of Virology.
[255] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[256] M. Froeyen,et al. Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120 , 2005, Journal of Biological Chemistry.
[257] M. Estes,et al. Noroviruses everywhere: has something changed? , 2006, Current opinion in infectious diseases.
[258] R. Dutch,et al. Paramyxovirus Fusion and Entry: Multiple Paths to a Common End , 2012, Viruses.
[259] R. Kannagi,et al. Human T-Cell Leukemia Virus-1 Encoded Tax Protein Transactivates α1→3 Fucosyltransferase Fuc-T VII, Which Synthesizes Sialyl Lewis X, a Selectin Ligand Expressed on Adult T-Cell Leukemia Cells , 1997 .
[260] M. Hart,et al. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. , 2002, AIDS research and human retroviruses.
[261] D. Ho,et al. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC. , 2011, AIDS research and human retroviruses.
[262] S. Harrison,et al. Specificity and Affinity of Sialic Acid Binding by the Rhesus Rotavirus VP8* Core , 2002, Journal of Virology.
[263] Kay-Hooi Khoo,et al. Glycans on influenza hemagglutinin affect receptor binding and immune response , 2009, Proceedings of the National Academy of Sciences.
[264] A. Bartesaghi,et al. Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure , 2010, PLoS pathogens.
[265] J. Whitsett,et al. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[266] N. Roberts. Anti-influenza drugs and neuraminidase inhibitors. , 2001, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[267] J. Esko,et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate , 1997, Nature Medicine.
[268] T. Geijtenbeek,et al. Langerin functions as an antiviral receptor on Langerhans cells , 2010, Immunology and cell biology.
[269] H. Klenk,et al. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety , 1997, Journal of virology.
[270] S. Harrison. Viral membrane fusion , 2008, Nature Structural &Molecular Biology.
[271] R. Eisenberg,et al. Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production , 1980, Journal of virology.
[272] R. Dwek,et al. Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.
[273] Nicolle H. Packer,et al. Mucin‐type O‐glycosylation – putting the pieces together , 2010, The FEBS journal.
[274] D. Burton,et al. GP120: target for neutralizing HIV-1 antibodies. , 2006, Annual review of immunology.
[275] M. Tate,et al. Glycosylation of the hemagglutinin modulates the sensitivity of H3N2 influenza viruses to innate proteins in airway secretions and virulence in mice. , 2011, Virology.
[276] F. Osorio,et al. Myeloid C-type lectin receptors in pathogen recognition and host defense. , 2011, Immunity.
[277] M. Clerici,et al. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. , 2010, ACS chemical biology.
[278] J. Kappes,et al. Uterine Epithelial Cell Regulation of DC-SIGN Expression Inhibits Transmitted/Founder HIV-1 Trans Infection by Immature Dendritic Cells , 2010, PloS one.
[279] C. Figdor,et al. Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses , 2000, Cell.
[280] H. Klenk,et al. The receptor‐destroying enzyme of influenza C virus is neuraminate‐O‐acetylesterase. , 1985, The EMBO journal.
[281] J. Paulson,et al. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. , 1983, Virology.
[282] H. Nauwynck,et al. Porcine reproductive and respiratory syndrome virus entry into the porcine macrophage. , 2010, The Journal of general virology.
[283] Fang Fang,et al. DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues , 2009, Antimicrobial Agents and Chemotherapy.
[284] W. Weis. Cell-surface carbohydrate recognition by animal and viral lectins. , 1997, Current opinion in structural biology.
[285] P. Reading,et al. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. , 1994, The Journal of general virology.
[286] Kimberly B. Ulett,et al. N-Linked Glycosylation Attenuates H3N2 Influenza Viruses , 2007, Journal of Virology.
[287] J. Goudsmit,et al. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. , 1994, Virology.
[288] R. Pal,et al. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[289] J. J. Batenburg,et al. Collectins: players of the innate immune system. , 2004, European journal of biochemistry.
[290] R. Wallis,et al. High-Affinity Glycopolymer Binding to Human DC-SIGN and Disruption of DC-SIGN Interactions with HIV Envelope Glycoprotein , 2010, Journal of the American Chemical Society.
[291] P. Mason,et al. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle , 1997, Journal of virology.
[292] Wakamiya,et al. Human mannan‐binding lectin inhibits the infection of influenza A virus without complement , 1999, Immunology.
[293] Henrik Clausen,et al. Location, location, location: new insights into O-GalNAc protein glycosylation. , 2011, Trends in cell biology.
[294] A. Dubart-Kupperschmitt,et al. Lentivirus degradation and DC‐SIGN expression by human platelets and megakaryocytes , 2006, Journal of thrombosis and haemostasis : JTH.
[295] P. Bates,et al. Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein , 2010, PLoS pathogens.
[296] L. Aschenbrenner,et al. DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis. , 2010, The Journal of antimicrobial chemotherapy.
[297] Oscar A. Negrete,et al. DC-SIGN Binds to HIV-1 Glycoprotein 120 in a Distinct but Overlapping Fashion Compared with ICAM-2 and ICAM-3* , 2004, Journal of Biological Chemistry.
[298] B. Wahrén,et al. Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals. Effects of elimination of the V3 N306 glycan. , 2001, Vaccine.
[299] L. Aschenbrenner,et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. , 2007, The Journal of infectious diseases.
[300] S. Akira,et al. Identification and functions of pattern-recognition receptors. , 2010, The Journal of allergy and clinical immunology.
[301] E. Thiry,et al. A multipotential beta -1,6-N-acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[302] Michael T. McManus,et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[303] Y. Kooyk,et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells , 2007, Nature Medicine.
[304] D. Weissman,et al. Constitutive and induced expression of DC‐SIGN on dendritic cell and macrophage subpopulations in situ and in vitro , 2002, Journal of leukocyte biology.
[305] P. Crocker,et al. Siglecs as positive and negative regulators of the immune system. , 2008, Biochemical Society transactions.
[306] M. McElrath,et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. , 2004, The Journal of infectious diseases.
[307] L. Morris,et al. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells. , 2012, Virology.
[308] A. Telenti,et al. Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides , 2012, PLoS biology.
[309] U. Švajger,et al. C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity , 2010, Cellular Signalling.
[310] H. Klenk,et al. Functional balance between haemagglutinin and neuraminidase in influenza virus infections , 2002, Reviews in medical virology.
[311] P. Desprès,et al. Dendritic‐cell‐specific ICAM3‐grabbing non‐integrin is essential for the productive infection of human dendritic cells by mosquito‐cell‐derived dengue viruses , 2003, EMBO reports.
[312] Jin Il Kim,et al. N-Linked Glycosylation in the Hemagglutinin of Influenza A Viruses , 2012, Yonsei medical journal.
[313] Houping Ni,et al. Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR , 2003, Journal of Virology.
[314] M. Chilosi,et al. Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5 , 2001, Journal of Virology.
[315] S. Crovella,et al. Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission , 2011, Human Immunology.
[316] Kristen D Yetming,et al. Ganglioside-Linked Terminal Sialic Acid Moieties on Murine Macrophages Function as Attachment Receptors for Murine Noroviruses , 2009, Journal of Virology.
[317] C. Garlanda,et al. An integrated view of humoral innate immunity: pentraxins as a paradigm. , 2010, Annual review of immunology.
[318] N. Haigwood,et al. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. , 1991, Journal of immunology.
[319] A. Dell,et al. Histo-Blood Group Antigens Act as Attachment Factors of Rabbit Hemorrhagic Disease Virus Infection in a Virus Strain-Dependent Manner , 2011, PLoS pathogens.
[320] Xiaowu Chen,et al. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. , 2000, Current medicinal chemistry.
[321] M. Palcic,et al. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors. , 2000, Glycobiology.
[322] R. Jackson,et al. Myxoma virus encodes an alpha2,3-sialyltransferase that enhances virulence. , 1999, Journal of virology.
[323] J. Whitsett,et al. Complementation of Pulmonary Abnormalities in SP-D(−/−) Mice with an SP-D/Conglutinin Fusion Protein* , 2002, The Journal of Biological Chemistry.
[324] Yasuo Suzuki,et al. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. , 2005, Biological & pharmaceutical bulletin.
[325] E. Schmidt,et al. Lectin-Dependent Enhancement of Ebola Virus Infection via Soluble and Transmembrane C-type Lectin Receptors , 2013, PloS one.
[326] F. Zoulim,et al. Glucosidase inhibitors as antiviral agents for hepatitis B and C. , 2007, Current opinion in investigational drugs.
[327] J. Peter-Katalinic,et al. Methods in enzymology: O-glycosylation of proteins. , 2005, Methods in enzymology.
[328] B. Mahy,et al. The Evolution and Emergence of RNA Viruses , 2010, Emerging Infectious Diseases.
[329] R. D. de Groot. Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses , 2006, Glycoconjugate Journal.
[330] R. Lamb,et al. Cell Surface Expression of Biologically Active Influenza C Virus HEF Glycoprotein Expressed from cDNA , 1999, Journal of Virology.
[331] É. Cohen,et al. Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-Child Transmission , 2012, PloS one.
[332] D. Duksin,et al. Antiviral activity of tunicamycin on herpes simplex virus , 1980, Antimicrobial Agents and Chemotherapy.
[333] Barbara Imperiali,et al. Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems. , 2006, Glycobiology.
[334] Kuender D Yang,et al. DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation , 2011, PLoS neglected tropical diseases.
[335] K. Hartshorn,et al. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells , 2007, Medical Microbiology and Immunology.
[336] C. F. Brewer,et al. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. , 2010, Glycobiology.
[337] Carolyn R. Bertozzi,et al. Essentials of Glycobiology , 1999 .
[338] M. Saleem,et al. DC-specific ICAM-3-grabbing nonintegrin mediates internalization of HIV-1 into human podocytes. , 2010, American journal of physiology. Renal physiology.
[339] Benhur Lee,et al. Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells Is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120-DC-SIGN Binding , 2002, Journal of Virology.
[340] M. Nacht,et al. The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities. , 1987, Virology.